Nanalysis Scientific (CVE:NSCI) Stock Price Up 12.5% – Should You Buy?

Nanalysis Scientific Corp. (CVE:NSCI) shares traded up 12.5% during trading on Wednesday . The stock traded as high as C$0.14 and last traded at C$0.14. Approximately 241,165 shares traded hands during mid-day trading, an increase of 285% from the average daily volume of 62,690 shares. The stock had previously closed at C$0.12.

Nanalysis Scientific Price Performance

The company has a debt-to-equity ratio of 71.72, a quick ratio of 1.10 and a current ratio of 1.42. The company’s 50-day moving average price is C$0.14 and its 200 day moving average price is C$0.15. The stock has a market capitalization of C$18.69 million, a P/E ratio of -2.70 and a beta of -0.52.

About Nanalysis Scientific

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries.